Skip to content

Clinical pregnancy rates of frozen embryo transfer with and without use of growth hormone in recipients of oocyte donation .

Clinical pregnancy rates of frozen embryo transfer with and without use of growth hormone in recipients of oocyte donation . - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070749
Enrollment
46
Registered
2024-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O090- Supervision of pregnancy with history of infertility

Interventions

Intervention1: Recombinant growth hormone: We have planned to conduct a multicentric RCT at OASIS fertility hospital at Bhubaneswar over a period of 1.5 years. Those patients planned for FET HRT cycl

Sponsors

OASIS FERTILITY HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients for FET HRT cycles with donor oocytes willing to take GH b) Embryos frozen by vitrification within the previous 2 years c) At least two embryos frozen per patient. d) Age above 30 years

Exclusion criteria

Exclusion criteria: a) Congenital or acquired uterine malformations b) Endometrial polyps and submucosal fibroids c) Intrauterine adhesion d) Patients for FET cycles with self oocytes

Design outcomes

Primary

MeasureTime frame
To find out the clinical pregnancy rates of frozen embryo transfer (FET) with the use of recombinant human growth hormone (rhGH) in oocyte donation programme. Timepoint: one and half years

Secondary

MeasureTime frame
Ongoing pregnancy ratesTimepoint: Three to 4 months from the time of recruitment

Countries

India

Contacts

Public ContactDr prasanta Kumar Nayak

OASIS fertility hospital-U unit of Sadguru healthcare services pvt.Ltd, Bhubaneswar

drpknayak2020@gmail.com9131330412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026